Gabelli & CO Investment Advisers, Inc. Exact Sciences Corp Transaction History

Gabelli & CO Investment Advisers, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $167,765 - $232,973	-2,314 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $208,815 - $287,051	2,314 New	2,314 $221,000
Q3 2019 Nov 01, 2019	SELL	$90.37 - $122.49 $393,651 - $533,566	-4,356 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$89.51 - $118.04 $9,488 - $12,512	106 Added 2.49%	4,356 $514,000
Q1 2019 May 02, 2019	BUY	$61.98 - $96.5 $6,198 - $9,650	100 Added 2.41%	4,250 $368,000
Q4 2018 Jan 30, 2019	BUY	$56.04 - $82.66 $232,566 - $343,039	4,150 New	4,150 $262,000

672

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.66B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.